MedTrace Logo

Using Implementation Intentions to Reduce Anger and Aggression in Adolescence

NCT03693209 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-11-19

No results posted yet for this study

Summary

This study will test whether making plans of action for situations that trigger anger is effective in reducing anger and aggression in adolescents with behavioural problems.

Participants will be assigned to three groups: a control group and two experimental groups. Participants assigned to the experimental groups will receive either one general anger trigger or a list of specific anger triggers in addition to a list of strategies that can be used to manage anger. Participants will be instructed to link the triggers with the strategies, thus creating action plans with an if-then structure. Participants assigned to the control group will receive the same lists. However, they will receive different instructions which will ask them to select separately the most encountered triggers and the most useful strategies.

It is expected that making plans will reduce the anger and aggression of participants. It is also expected that the reduction will be larger for participants with low violent intentions, low callous-unemotional traits and low impulsivity.

Conditions

  • Aggression
  • Anger

Interventions

BEHAVIORAL

Volitional Help Sheet (VHS)

VHS with a general anger trigger and 10 anger management strategies

BEHAVIORAL

Volitional Help Sheet (VHS)

VHS with 10 specific anger triggers and 10 anger management strategies

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • University of Sheffield

    lead OTHER

Principal Investigators

  • Laura Castillo-Eito, Msc · University of Sheffield

  • Christopher J Armitage, PhD · University of Manchester

  • Paul Norman, PhD · University of Sheffield

  • Richard Rowe, PhD · University of Sheffield

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-16
Primary Completion
2019-06-28
Completion
2019-06-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03693209 on ClinicalTrials.gov